Comparison between PD‐1/PD‐L1 inhibitors (nivolumab, pembrolizumab, and atezolizumab) in pretreated NSCLC patients: Evidence from a Bayesian network model. Issue 11 (25th September 2018)

Record Type:
Journal Article
Title:
Comparison between PD‐1/PD‐L1 inhibitors (nivolumab, pembrolizumab, and atezolizumab) in pretreated NSCLC patients: Evidence from a Bayesian network model. Issue 11 (25th September 2018)
Main Title:
Comparison between PD‐1/PD‐L1 inhibitors (nivolumab, pembrolizumab, and atezolizumab) in pretreated NSCLC patients: Evidence from a Bayesian network model
Authors:
Wu, Yingcheng
Lin, Lifeng
Shen, Yanting
Wu, Huiqun
Abstract:
Is Part Of:
International journal of cancer. Volume 143:Issue 11(2018)
Journal:
International journal of cancer
Issue:
Volume 143:Issue 11(2018)
Issue Display:
Volume 143, Issue 11 (2018)
Year:
2018
Volume:
143
Issue:
11
Issue Sort Value:
2018-0143-0011-0000
Page Start:
3038
Page End:
3040
Publication Date:
2018-09-25
Subjects:
Cancer -- Periodicals
Cancer -- Prevention -- Periodicals
616.994
Journal URLs:
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0215 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:
10.1002/ijc.31733 ↗
Languages:
English
ISSNs:
0020-7136
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 4542.156000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
8791.xml